Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Ovarian clear cell carcinoma recurrence presenting as subcutaneous nodules
1The Royal Women's Hospital, Melbourne, Victoria, Australia
*Corresponding Author(s): J. Wade E-mail: Jessica.Wade@thewomens.org.au
Skin metastasis is a rare form of ovarian carcinoma spread and is associated with widespread disease and a poor prognosis. The authors present a case of a patient, with a past history of ovarian clear cell carcinoma, who presented with subcutaneous nodules as the first sign of recurrent metastatic disease.
Ovarian cancer; Ovarian clear cell carcinoma; Skin metastasis; Subcutaneous nodule; Case report.
J. Wade,S. Armon,O.M. McNally. Ovarian clear cell carcinoma recurrence presenting as subcutaneous nodules. European Journal of Gynaecological Oncology. 2016. 37(4);575-577.
[1] Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D.: “Global cancer statistics”. CA Cancer J. Clin., 2011, 61, 69.
[2] Despierre E., Yesilyurt B.T., Lambrechts S., Johnson N., Verheijen R., van der Burg M., et al.: “Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment”. Int. J. Gynecol. Cancer, 2014, 24, 468.
[3] Pectasides D., Pectasides E., Psyrri A., Economopoulos T.: “Treatment issues in clear cell carcinoma of the ovary: a different entity?” Oncologist, 2006, 11, 1089.
[4] Chan J., Teoh D., Hu J., Shin J., Osann K., Kapp D.: “Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers”. Gynecol. Oncol., 2008, 109, 370.
[5] Dauplat J., Hacker N., Nieberg R., Berek J., Rose T., Sagae S.: “Distant metastases in epithelial ovarian carcinoma”. Cancer, 1987, 60, 1561.
[6] Cormio G., Rossi C., Cazzolla A., Resta L., Loverro G., Greco P., et al.: “Distant metastases in ovarian carcinoma”. Int. J. Gynecol. Cancer, 2003, 13, 125.
[7] Lookingbill D.P., Spangler N., Helm K.F.: “Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients”. J. Am. Acad. Dermatol., 1993, 29, 228.
[8] Australian Cancer Incidence and Mortality (ACIM) Books: “Ovarian Cancer for Australia (ICD10 C56)”. Available at: http://www.aihw.gov.au/acim-books/
[9] Lengyel E.: “Ovarian cancer development and metastasis”. Am. J. Pathol., 2010, 177, 1053.
[10] Cheng B., Lu W., Xiaoyun W., YaXia C., Xie X.: “Extra-abdominal metastases from epithelial ovarian carcinoma”. Int. J. Gynecol. Cancer, 2009, 19, 611.
[11] Warraich N., Mitchell J., Holliday H., Iftikhar S.: “Ovarian cancer presenting as chest wall subcutaneous nodule: a case report and literature review”. Gynaecol. Oncol., 2006, 100, 430.
[12] Dvoretsky P., Richards K., Angel C., Rabinowitz L., Stoler M.,Beecham J., et al.: “Distribution of disease at autopsy in 10 0 women with ovarian cancer”. Hum. Pathol., 1988, 19, 57.
[13] Wiechert A., Garrett L., Lin G., Goodman A.: “Management of askin metastasis in a patient with advanced ovarian canc er”. Gynaecol. Oncol. Rep., 2012, 2, 124.
[14] Cormio G., Capotorto M., DiVagno G., Cazzolla A., Carriero C., Selvaggi L.: “Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature”. Gynaecol. Oncol., 2003, 90, 682.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top